跳至主要内容
临床试验/ACTRN12619001044112
ACTRN12619001044112招募中未知

Evaluation of the Diagnostic Accuracy of a Multiplex Test for the Early Diagnosis of Melanoma

Edith Cowan university0 个研究点目标入组 1,000 人开始时间: 2019年7月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Subject Population
  • The study population will be drawn from WAKMAS, private and public practices and hospitals. The patients will provide a blood sample prior to the time of biopsy for an early stage cutaneous melanoma.
  • Inclusion Criteria:
  • Participants who have an abnormal skin lesion thought to be melanoma or other non-melanoma skin cancers or participants who have recently been diagnosed with other types of primary cancer or an autoimmune disease
  • >18 years
  • Written informed consent
  • Willing and able to comply with study blood collection protocol
  • Willing to provide relevant biopsy pathology report

排除标准

  • Exclusion Criteria:
  • People previously diagnosed with metastatic melanoma (TNM stage III and IV)
  • Previously diagnosed with other cancers (excluding skin cancers)
  • Surgical procedure in the last three months
  • Previously diagnosed with an autoimmune disease

研究者

相似试验

撤回
不适用
The Diagnostic Accuracy of Subtractionless multi-point Dixon Peripheral MR Angiography The DOGMA TRIAatherosclerosisperipheral arterial disease10003216
NL-OMON41042niversitair Medisch Centrum Utrecht100
招募中
不适用
Evaluation of the accuracy of diagnosis by simple scoring system for SNADET
JPRN-UMIN000047039TT Medical Center Tokyo1,000
进行中(未招募)
1 期
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864
EUCTR2012-001864-30-BEMolecular Insight Pharmaceuticals, Inc100
进行中(未招募)
不适用
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 15.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001864-30-HUMolecular Insight Pharmaceuticals, Inc100
进行中(未招募)
1 期
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864
EUCTR2012-001864-30-CZMolecular Insight Pharmaceuticals, Inc100